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Clinical value of dark-blood late gadolinium
enhancement cardiovascular magnetic
resonance without additional
magnetization preparation
Robert J. Holtackers1,2,7†, Caroline M. Van De Heyning2,3,4,5†, Muhummad Sohaib Nazir2,3, Imran Rashid2,3,
Ioannis Ntalas2,3, Haseeb Rahman2,3, René M. Botnar2,6 and Amedeo Chiribiri2*
Abstract
Background: For two decades, bright-blood late gadolinium enhancement (LGE) cardiovascular magnetic resonance
(CMR) has been considered the reference standard for the non-invasive assessment of myocardial viability. While
bright-blood LGE can clearly distinguish areas of myocardial infarction from viable myocardium, it often suffers from
poor scar-to-blood contrast, making subendocardial scar difficult to detect. Recently, we proposed a novel dark-blood
LGE approach that increases scar-to-blood contrast and thereby improves subendocardial scar conspicuity. In the
present study we sought to assess the clinical value of this novel approach in a large patient cohort with various non-
congenital ischemic and non-ischemic cardiomyopathies on both 1.5 T and 3 T CMR scanners of different vendors.
Methods: Three hundred consecutive patients referred for clinical CMR were randomly assigned to a 1.5 T or 3 T
scanner. An entire short-axis stack and multiple long-axis views were acquired using conventional phase sensitive
inversion recovery (PSIR) LGE with TI set to null myocardium (bright-blood) and proposed PSIR LGE with TI set to null
blood (dark-blood), in a randomized order. The bright-blood LGE and dark-blood LGE images were separated,
anonymized, and interpreted in a random order at different time points by one of five independent observers. Each
case was analyzed for the type of scar, per-segment transmurality, papillary muscle enhancement, overall image quality,
observer confidence, and presence of right ventricular scar and intraventricular thrombus.
Results: Dark-blood LGE detected significantly more cases with ischemic scar compared to conventional bright-blood
LGE (97 vs 89, p = 0.008), on both 1.5 T and 3 T, and led to a significantly increased total scar burden (3.3 ± 2.4 vs 3.0 ±
2.3 standard AHA segments, p = 0.015). Overall image quality significantly improved using dark-blood LGE compared to
bright-blood LGE (81.3% vs 74.0% of all segments were of highest diagnostic quality, p = 0.006). Furthermore, dark-
blood LGE led to significantly higher observer confidence (confident in 84.2% vs 78.4%, p = 0.033).
Conclusions: The improved detection of ischemic scar makes the proposed dark-blood LGE method a valuable
diagnostic tool in the non-invasive assessment of myocardial scar. The applicability in routine clinical practice is further
strengthened, as the present approach, in contrast to other recently proposed dark- and black-blood LGE techniques, is
readily available without the need for scanner adjustments, extensive optimizations, or additional training.
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Background
Although coronary artery disease related deaths have de-
clined over the past 10 years, it remains the leading cause of
death worldwide for both men and women [1]. Since survi-
vors of previous myocardial infarction (MI) face an increased
risk of new cardiovascular events, there is great focus on de-
tecting and accurately assessing the infarcted region [2]. Im-
portant aspects of this assessment include determining the
infarct’s location, size, and transmural extent. Over a decade
ago it was first demonstrated that even small regions of MI
were associated with large increases in major adverse cardiac
events [3, 4], while regional functional recovery following re-
vascularization was highly dependent on the transmural ex-
tent of the infarct [5–8]. It is clear that this information is an
essential requisite for patient management decisions and se-
lection of the optimal therapeutic approach.
Bright-blood late gadolinium enhancement (LGE) cardio-
vascular magnetic resonance (CMR) has been considered the
reference standard in the non-invasive assessment of myo-
cardial viability for almost two decades now. Its ability to
clearly depict areas of myocardial infarction from viable
myocardium is well established, making LGE a widely ac-
cepted component of standard clinical CMR protocols. By
nulling the magnetization level of viable myocardium, its
dark appearance can easily be distinguished from the bright
appearance of scar tissue. However, as the adjacent LV blood
pool can have similar T1 values at 10min post-injection with
almost equally bright signal, the border between scar and
blood can be difficult to delineate. In particular patients with
thin subendocardial scarring patterns in this border zone are
susceptible to this limitation, where the apparent volume of
scar tissue can be significantly reduced, or even completely
obscured. Furthermore, blood pool signal can mimic scar tis-
sue and lead to false positive observations. This makes sub-
endocardial scar patterns difficult to detect and clearly
delineate using conventional bright-blood LGE. Allowing
additional time after contrast administration partly resolves
this challenge, as due to contrast washout over time the scar
and blood T1 values will start to diverge, thereby increasing
scar-to-blood contrast. However, this solution is unfavour-
able in daily clinical practice, where already long CMR exam-
inations and high clinical demand result in significant time-
pressures.
Since the initial validation against histology in 1999 [9], the
clinical utility of LGE has broadened and several variations
in the technique’s application have been introduced. These
advances include new reconstruction techniques [10–14],
free-breathing sequences using motion correction algorithms
[15–18], and techniques to improve image contrast, in par-
ticular the poor scar-to-blood contrast [18–26]. These tech-
niques improve scar-to-blood contrast by using additional
magnetization preparation before or after the 180° inversion
pulse. Multiple approaches have been proposed, including
T2 preparation [18–23], magnetization transfer [23, 24], T1
rho using spin locking [24], and multiple subsequent inver-
sion pulses [25, 26], each creating a different type of contrast
and improving subendocardial scar conspicuity. However,
the use of additional magnetization preparation mechanisms
often requires adjustments to the scanner software, extensive
optimizations for new sequence parameters, additional train-
ing for radiographers, and most importantly, are not readily
available in routine clinical practice. Furthermore, specific
absorption rate levels are increased due to the additional ra-
diofrequency pulses.
Recently, we proposed a novel dark-blood LGE approach
that significantly increases scar-to-blood contrast without
using any additional magnetization preparation mechanism
[27]. In a small pilot study performed on patients with previ-
ous MI, nulling the LV blood pool instead of the myocar-
dium (by choosing a shorter TI), in combination with phase-
sensitive inversion-recovery (PSIR), has shown to provide
clear benefits for the identification of subendocardial scar.
These experiments demonstrated that this novel dark-blood
LGE technique has a significantly higher scar-to-blood con-
trast-to-noise ratio (CNR) than conventional bright-blood
LGE, while maintaining the scar-to-myocardium CNR. In
the present work we sought to assess the clinical value of this
novel dark-blood approach for the detection of ischemic in-
jury in a large cohort of patients on both 1.5 and 3T, in
comparison with reference standard bright-blood LGE im-
aging. As no additional magnetization preparation mecha-
nisms are required, the novel approach is readily available in
routine clinical setting without the need for scanner software
adjustments, extensive parameter optimizations, and add-
itional training.
Methods
Study population
A total of 300 consecutive patients referred for clinical CMR
including LGE between March and September 2017 were in-
cluded. Patients were randomly allocated to either a 1.5 T or
3T clinical CMR scanner of different vendors: 1.5 T Ingenia
(Philips Healthcare, Best, the Netherlands) [n= 100], 1.5 T
Aera (Siemens Healthineers, Erlangen, Germany) [n = 100],
and 3TAchieva TX (Philips Healthcare) [n = 100]. The study
was approved by the local ethics committee (15/NS/0030)
and was conducted according to the Declaration of Helsinki.
Written informed consent was obtained from all patients for
inclusion in the study and for additional CMR imaging dur-
ing their clinical CMR exam.
LGE imaging
A routine clinical CMR protocol was used to obtain a
cine stack of the short-axis view covering the entire left
ventricle (LV) and right ventricle (RV) (10–15 slices),
followed by cine images of the two-, three-, and four-
chamber view. After an intravenous injection of 0.2
mmol/kg gadobutrol (Gadovist, Bayer, Berlin, Germany),
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both conventional bright-blood LGE and proposed dark-
blood LGE images were acquired in identical cardiac
projections (full short-axis stack covering the entire LV
and RV + three long-axis views). A 1:1 randomisation
scheme was used to decide the order of acquisition of
the LGE images. In 150 consecutive subjects (50 for each
CMR scanner), conventional bright-blood LGE was per-
formed first (starting at 10min post-injection), followed by
dark-blood LGE (starting at 20min post-injection). In an-
other 150 consecutive subjects (50 for each CMR scanner),
the scans were acquired in reversed order: dark-blood LGE
first (10min post-injection), followed by conventional bright-
blood LGE (20min post-injection). The mechanism for the
dark-blood LGE acquisition technique without using add-
itional magnetization preparation has recently been de-
scribed in detail [27]. Both methods used a PSIR acquisition
and reconstruction, preceded by a Look-Locker sequence to
determine the TI. For conventional bright-blood LGE, the TI
was set to null viable LV myocardium, while for dark-blood
LGE the TI was set to null the LV blood pool (Fig. 1), leading
to a dark-gray appearance of the blood in the PSIR image.
Specific sequence details for all three CMR scanners reflect
the local clinical protocol and can be found in Table 1. Note
that only the TI was adjusted in the local clinical protocols
to acquire dark-blood LGE images. All images were acquired
in the mid-diastolic resting period using 10–15 s breath-hold
scans, depending on the subject’s heart rate. The given con-
trast dose reflects local protocol and current international
guidelines [28].
Image analysis
The acquired image data of all subjects was randomly
assigned for review to one of five independent level III
trained observers blinded to subject characteristics. For each
subject, the conventional bright-blood and dark-blood PSIR
LGE images were separated, anonymized, and analyzed in
random order at different time points. Thereby, the bright-
blood and dark-blood LGE images of the same subject were
never presented in sequence to the reader. The images were
shown and interpreted according to the criteria recom-
mended by the Society for Cardiovascular Magnetic Reson-
ance (SCMR) [29]. All images were analysed using OsiriX
v9.0 64-bit (Pixmeo, Geneva, Switzerland).
Overall image quality was rated on a four-point Likert
scale for each method: 0) non-diagnostic, 1) low [≥ two
segments non-diagnostic], 2) medium [one segment
non-diagnostic], or 3) high [all segments correctly iden-
tified]). In case the image quality of either of the two
methods was scored as 0 (non-diagnostic), the subject
was excluded from further analysis. Subjects were classi-
fied with each LGE method as having: 0) no scar, 1) is-
chemic scar, 2) non-ischemic scar, or 3) both ischemic
and non-ischemic LV scar. In case the classifications, as
assigned by each method, did not match, consensus was
provided by a level III observer with > 10 years of experi-
ence in CMR. In case any ischemic scar was observed,
the entire short-axis stack was analyzed for maximum
scar transmurality on a per-segment basis using the
American Heart Association (AHA) model (17 seg-
ments). The transmural extent in each segment was
evaluated as a percentage of the local total wall thickness
using a five-point Likert scale: 0) no scar, 1) 1–25%, 2)
26–50%, 3) 51–75%, or 4) 76–100%. Total scar burden
was calculated as the sum of all segments multiplied by
their corresponding maximum transmurality percentage
(maximum scar burden = 17). Observer confidence in
scar detection and analysis was rated using a binary
scale: 0) not confident or 1) confident. In addition, the
presence of papillary muscle enhancement, RV scar, and
LV thrombus were each assessed separately on a binary
scale: 0) not present or 1) present. In a subgroup of 20
subjects, intra- and inter-observer agreement was
assessed for both the presence of scar as well as total
scar burden.
Fig. 1 A series of short-axis images with varying inversion times (TI) (Look-Locker scan) in a subject with myocardial scar, acquired at ten minutes
post-injection. The blood pool, viable myocardium, and myocardial scar each reach their own nulling point at different TIs. Note that for
conventional bright-blood late gadolinium enhancement (LGE) the TI is set to null viable myocardium (blue arrow in frame 9, TI = 248ms), while
for dark-blood LGE the TI is set to null the blood pool (orange arrow in frame 5, TI = 150ms)
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Statistical analysis
All statistical analyses were performed using SPSS Statis-
tics 23 (Statistical Package for the Social Sciences (SSPS),
International Business Machines, Inc., Armonk, New
York, USA). Results are expressed as mean ± standard
deviation or as percentage unless otherwise specified.
Differences in the detection of myocardial scar between
conventional bright-blood LGE and dark-blood LGE
were evaluated using McNemar tests. Differences in
total scar burden as assessed by both methods were eval-
uated using either the paired-sample t-test (normally
distributed data) or the non-parametric Wilcoxon
signed-rank test (non-normally distributed data). Nor-
mality of data was confirmed using the Shapiro-Wilk
test. Differences in image quality and observer confi-
dence between both methods were evaluated using a
Wilcoxon signed-rank test and the McNemar test, re-
spectively. Intra- and inter-observer variability in the
presence of scar was assessed by calculating Cohen’s
kappa and Fleiss’ kappa coefficients, respectively. Intra-
and inter-observer variability in the total scar burden
was assessed by calculating the intraclass correlation co-
efficient. Coefficients were considered: ‘poor’ < 0.40, ‘fair’
between 0.40 and 0.59, ‘good’ between 0.60 an 0.74, and
‘excellent’ > 0.75. All statistical tests were two-tailed and
p-values < 0.05 were considered significant.
Results
Study population
Baseline characteristics of the study population are sum-
marized in Table 2. Complete conventional bright-blood
and dark-blood LGE data sets were acquired in all sub-
jects (n = 300). Eight subjects (2.7%) had non-diagnostic
bright-blood and/or dark-blood LGE image quality due
to arrhythmia (n = 1), image artefacts (including respira-
tory motion, wrap-around, and shading) (n = 6), or a
combination of both (n = 1), and were excluded from
further analysis. Exclusion of these eight patients was
caused by non-diagnostic image quality in the bright-
blood LGE images only (n = 4), dark-blood LGE images
only (n = 1), or both sets of images (n = 3). Statistical
analysis was therefore performed on a population of 292
subjects. In total 4964 segments were analysed for LGE.
LV scar detection
An ischemic/subendocardial LV scar pattern was de-
tected in 89 subjects by bright-blood LGE and in 97 sub-
jects by dark-blood LGE (30.5% vs 33.2%, p = 0.008). All
subjects with a definite diagnosis of ischemic scar on
bright-blood LGE were also correctly identified by dark-
blood LGE imaging (Figs. 2 and 3). However, eight sub-
jects (8.3%) were declared free of any ischemic scar
using conventional bright-blood LGE, but showed sub-
endocardial enhancement using dark-blood LGE (Fig. 4).
This effect was observed regardless of which sequence
was acquired first (4 cases for each order of acquisition),
and of the type of scanner used (Siemens 1.5T Aera: n = 1;
Philips 1.5T Ingenia T: n = 4; Philips 3T Achieva: n = 3).
Six out of these eight subjects were already known with is-
chemic heart disease (myocardial infarction [n = 2], previ-
ous percutaneous coronary intervention [n = 2], previous
coronary artery bypass graft [n = 1], or a combination of
myocardial infarction and revascularization [n = 1]). Total
scar burden in subjects with ischemic scar was signifi-
cantly higher on dark-blood LGE images compared to
bright-blood LGE images (3.3 ± 2.4 vs 3.0 ± 2.3 standard
AHA segments, p = 0.015; Figs. 5 and 6). Non-ischemic
scar patterns were observed in 46 and 44 subjects with
bright-blood LGE and dark-blood LGE, respectively
(15.8% vs 15.1%). Although areas of non-ischemic scar
were missed in two cases using dark-blood LGE in the
present study (Fig. 7), interestingly, no cases of non-ische-
mic scar were missed when dark-blood LGE was per-
formed at 10min post-injection.
Detection of papillary muscle enhancement, RV scar, and
areas of thrombus
Papillary muscle enhancement was detected in 17 (19.1%)
subjects with ischaemic scar using conventional bright-
blood LGE and in 34 (35.1%) subjects with ischaemic scar
using dark-blood LGE. RV infarction/fibrosis was detected
in 6 and 7 cases using bright-blood LGE and dark-blood
Table 1 Phase-sensitive inversion-recovery LGE pulse sequence parameters
Philips Ingenia Siemens Aera Philips Achieva TX
(n = 100) (n = 100) (n = 100)
Field strength (T) 1.5 1.5 3.0
Readout type T1-TFE TrueFISP T1-TFE
Echo time (TE, ms) 3.0 1.2 2.0
Repetition time (TR, ms) 6.2 2.9 3.6
Flip angle (°) 25 45 25
Slice thickness (mm) 10 8 8
Acquired resolution (mm2) 1.60 × 1.90 1.41 × 1.89 1.61 × 1.61
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LGE, respectively. The single case that was detected by
dark-blood LGE only, was later diagnosed with arrhyth-
mogenic RV cardiomyopathy (ARVC). No difference in
the detection of LV thrombus was observed between both
LGE methods (10 cases in total, Fig. 2).
Overall image quality
Overall image quality for the entire study population (n =
300) is illustrated in Fig. 8. Image quality was significantly
better using dark-blood LGE than conventional bright-
blood LGE (p = 0.006). All LV segments were of the high-
est diagnostic quality in 74.0% vs 81.3% of the subjects
using conventional bright-blood and dark-blood LGE, re-
spectively. Non-diagnostic image quality was observed in
7 (2.3%) and 4 (1.3%) cases using conventional bright-
blood LGE and dark-blood LGE, respectively, which led to
the exclusion of 8 cases in total. In the subgroup where
dark-blood LGE was performed first at 10min post-injec-
tion, no significant difference in overall image quality was
found between the two methods (p = 0.563). However,
when conventional bright-blood was performed first,
dark-blood LGE showed significantly higher overall image
quality (p = 0.002).
Observer confidence
Significantly higher observer confidence was found using
dark-blood LGE compared to conventional bright-blood
LGE (p = 0.033). Observers were confident in in 78.4%
vs 84.2% of the subjects (n = 292) using conventional
bright-blood and dark-blood LGE, respectively. In the
subgroup where dark-blood LGE was performed first at
10 min post-injection, no significant difference in obser-
ver confidence was found between the two methods (p >
0.999). However, when conventional bright-blood was
performed first, dark-blood LGE showed significantly
higher observer confidence (p = 0.005).
Intra- and inter-observer agreement
Complete intra-observer agreement in the presence of scar
was observed for both conventional bright-blood LGE and
dark-blood LGE (κ= 1.00). For the inter-observer variability
in the presence of scar, excellent agreement was found for
both conventional bright-blood LGE (κ= 0.90) and dark-
blood LGE (κ= 0.85). For the assessed total scar burden, ex-
cellent intra-observer agreement was found for both conven-
tional bright-blood LGE (ICC= 0.95) and dark-blood LGE
(ICC= 0.99). For the inter-observer variability in total scar
burden, excellent agreement was found for both conven-
tional bright-blood LGE (ICC= 0.77) and dark-blood LGE
(ICC= 0.88).
Discussion
The aim of this study was to assess the clinical value of
a novel dark-blood LGE approach, which does not re-
quire any additional magnetization preparation, in a
large unselected cohort of 300 consecutive patients on
multiple scanners with varying field strengths and from
different vendors. This study shows that dark-blood LGE
is more sensitive than conventional bright-blood LGE in
the detection of ischemic scar, regardless of the field
Table 2 Baseline characteristics of study population (n = 300)
Age (years) 55 ± 16
Gender (male, %) 179 (59.7%)
Weight (kg) 83 ± 20
Length (cm) 171 ± 10
BMI (kg / m2) 28.2 ± 5.9
BSA (m2) 2.0 ± 0.3
LVEDVi (mL/m2) 92 ± 30
LVESVi (mL/m2) 48 ± 30
LVSVi (mL/m2) 44 ± 10
LVEF (%) 51 ± 14
RVEF (%) 55 ± 10
Known significant CAD (n, %) 68 (22.7%)
Previous myocardial infarction (n, %) 48 (16.0%)
Previous PCI (n, %) 32 (10.7%)
Previous CABG (n, %) 10 (3.3%)
Indication for CMR (n, %)
Cardiomyopathy 172 (57.3%)
Myocardial infarction / viability 52 (17.3%)
Myocarditis 33 (11.0%)
Aortic pathology 3 (1.0%)
Valvular disease 2 (0.7%)
Pericardial disease 3 (1.0%)
Cardiac mass 1 (0.3%)
Stress perfusion 102 (34.0%)
Final diagnosis (n, %)
Normal 93 (31.0%)
Non-ischemic cardiomyopathy 80 (26.7%)
Myocardial infarction 87 (29.0%)
Ischemia 34 (11.3%)
Myocarditis 17 (5.7%)
Aortic pathology 2 (0.7%)
Valvular disease 4 (1.3%)
Pericardial disease 4 (1.3%)
Cardiac mass 0 (0%)
Other 1 (0.3%)
Values are n, mean ± standard deviation, or frequency (%). Subjects may be
known with multiple indications for CMR and/or multiple final diagnoses
BMI body mass index, BSA body surface area, CABG coronary artery bypass
graft, CAD coronary artery disease, CMR cardiovascular magnetic resonance,
LVEDVi indexed left-ventricular end-diastolic volume, LVEF left-ventricular
ejection fraction, LVESVi indexed left-ventricular end-systolic volume, LVSVi
indexed left-ventricular stroke volume, PCI percutaneous coronary
intervention, RVEF right-ventricular ejection fraction
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strength or scanner vendor, with higher average scar
burden, increased overall image quality, and improved
observer confidence. Dark-blood LGE led to the detec-
tion of ischemic scar patterns in subjects that were
deemed free of scar by conventional bright-blood LGE,
which has implications for patient management through
the appropriate administration of secondary preventive
therapies. Furthermore, no cases of LV thrombus were
missed by dark-blood LGE in comparison to conven-
tional bright-blood LGE.
Accurate subendocardial scar detection and delinea-
tion is crucial in patients with previous MI, as current
treatment strategies are based on this assessment and
the presence of even small areas of myocardial scar are
Fig. 2 Bright-blood and dark-blood LGE images of a subject with myocardial infarction and a large apical thrombus. Panel a: Conventional bright-
blood phase sensitive inversion recovery (PSIR) LGE images of the short-axis at mid-ventricular level (SA), two-chamber view (2CH), three-chamber
view (3CH), and four-chamber view (4CH), which show a myocardial infarction in the left anterior descending (LAD)-territory with transmurality
ranging from 75 to 100% and a large area of left ventricular (LV) thrombus in the apex (orange arrow). Panel b: Dark-blood PSIR LGE images of
the same views. Although the myocardial infarction was clearly seen by both LGE methods, the transmural extent was challenging to assess on
the bright-blood LGE images due to poor definition of the border between scar and LV blood. In contrast, both the short-axis view and long-axis
views obtained by dark-blood LGE allowed clear delineation of the (transmural extent of the) infarcted area (blue arrows). Additionally, the area of
LV thrombus is still clearly visible due to the dark-blood effect (blood appears dark gray) rather than a black-blood effect. In this case,
conventional LGE and dark-blood LGE were performed at 10 min and 20min post-injection, respectively. For specific scan details, see ‘Philips
Ingenia’ at Table 1
Fig. 3 Short-axis bright-blood and dark-blood LGE images of a subject with myocardial infarction. Panel a: Conventional bright-blood
phase sensitive inversion recovery (PSIR) LGE images of the short-axis from base to apex, which show a subendocardial infarction of the basal and
mid inferolateral and lateral wall, and near-transmural infarction of the apical lateral wall. The short-axis views obtained by bright-blood LGE could
not accurately visualize the transmural extent of the myocardial infarction Panel b: Dark-blood PSIR LGE images of the same views. In contrast to
conventional bright-blood LGE (as shown in panel a), the short-axis views obtained by dark-blood LGE allowed clear delineation of the
myocardial infarction (blue arrows). Furthermore, focal subendocardial LGE was detected in the apical septum (orange arrow), which was missed
using bright-blood LGE only. Please note the presence of minor image artefacts caused by respirational motion, which are not inherently related
to the proposed dark-blood LGE and are visible on both conventional as well as dark-blood LGE images. In this case, conventional LGE and dark-
blood LGE were performed at 10 min and 20 min post-injection, respectively. For specific scan details, see ‘Philips Achieva TX’ at Table 1
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prognostically significant [3, 4]. Conventional bright-blood
LGE using myocardium nulling is not always able to detect
these areas immediately at 10min after injection. As the con-
trast between subendocardial scar and the blood pool de-
pends on a number of variables including gadolinium
clearance, performing conventional bright-blood LGE later
after contrast injection will readily increase subendocardial
conspicuity [30]. However, even in the subgroup where
bright-blood LGE was performed later and was expected to
have superior contrast, dark-blood LGE (already performed
at 10min post-injection) showed increased subendocardial
scar detection, potentially increasing the efficiency of clinical
protocols.
Other solutions to improve scar-to-blood contrast for bet-
ter subendocardial scar conspicuity include numerous re-
cently proposed methods that use additional magnetization
preparation mechanisms to suppress LV blood pool signal
[18–26]. However, a potential disadvantage of these dark-
and black-blood methods is the decrease in scar-to-myocar-
dium contrast, potentially compromising the detection of
non-ischemic scar compared to bright-blood LGE [31]. In
contrast, dark-blood LGE without magnetization preparation
Fig. 4 Short-axis bright-blood and dark-blood LGE image of all eight discordant cases. Conventional bright-blood (upper row) and dark-blood
(lower row) phase sensitive inversion recovery (PSIR) LGE short-axis images of all eight discordant cases. Areas of infarction are indicated by blue
arrows. Note that these areas of infarction could have been recognized using conventional bright-blood LGE when the dark-blood images would
have been shown simultaneously. However, when only the conventional bright-blood images were shown, these areas were missed and the
patients were declared free of any ischemic scar, while dark-blood LGE showed clear hyperenhancement. Patient 2, 3, 4, 5, 6, and 8 had known
coronary artery disease. In each patient, the yellow star indicates which method was performed first (at 10 min), while the two letters indicate the
CMR system used for each study (see Table 1 for specific scan details, PI = Philips 1.5T Ingenia, SA = Siemens 1.5T Aera, PA = Philips 3T Achieva TX)
Fig. 5 Bright-blood and dark-blood LGE images of a subject with thin subendocardial infarction. Panel a: Conventional bright-blood phase
sensitive inversion recovery (PSIR) LGE images of the short-axis at mid-ventricular level (SA), two-chamber view (2CH), three-chamber view (3CH),
and four-chamber view (4CH), which show a possible subendocardial infarction in the LAD territory. The transmurality of the scar is not well
defined. Panel b: Dark-blood PSIR LGE images of the same views reveal a 25% subendocardial myocardial infarction (blue arrows) in the septal
segments and 25–50% transmurality in the apical lateral wall. Furthermore, the short-axis dark-blood LGE image shows enhancement of the
anterolateral papillary muscle (orange arrow), which was not observed using conventional bright-blood LGE. In this case, conventional LGE and
dark-blood LGE were performed at 20min and 10 min post-injection, respectively. For specific scan details, see ‘Philips Ingenia’ at Table 1
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is able to maintain, or even exceed, the scar-to-myocardium
contrast of conventional LGE, in addition to its superior
scar-to-blood contrast [32].
Another important feature to consider when assessing the
diagnostic capabilities of the proposed dark-blood LGE
method is the accuracy of LV thrombus detection. Areas of
LV thrombus can frequently be found in dysfunctional
ventricles, most likely in correspondence with myocardial
scar and wall motion abnormalities. When not identified and
treated correctly, they can potentially result in life-threaten-
ing complications such as embolic myocardial infarction or
cerebrovascular accident. As thrombus is characterized by its
black appearance, conventional bright-blood LGE (or prefer-
ably early gadolinium enhancement) provides excellent con-
trast between the bright-blood and the black thrombus.
Recently, various black-blood LGE approaches have been
proposed that completely null the blood signal to improve
subendocardial scar detection. As blood is rendered com-
pletely black using these sequences, thrombus may then
seem to be part of the blood pool. However, by causing a
dark-blood effect rather than a complete black-blood effect,
blood will appear dark-gray and still allows the visualization
of areas of thrombus with similar accuracy as conventional
bright-blood LGE (Fig. 2) [27].
This study illustrated the clinical performance of a novel
dark-blood LGE approach against conventional bright-
blood LGE in a real-world situation. A large unselected
cohort of 300 consecutive patients referred for clinical
CMR including LGE was used, representing a typical
everyday non-congenital case mix of ischemic and non-is-
chemic cardiomyopathies. The improved detection of is-
chemic scar, as well as the reliable detection of non-
ischemic scar, RV scar, and LV thrombus, all achievable at
10 minutes post-injection, make the proposed dark-blood
LGE method a viable and time-efficient alternative to con-
ventional bright-blood LGE. These findings are of high ap-
plicability in most routine clinical settings, as the
proposed dark-blood LGE approach, in contrast to other
recently proposed dark- and black-blood techniques, is
Fig. 6 Bland-Altman plot of total scar burden as assessed by both conventional and dark-blood LGE. Mean total scar burden and difference in
total scar burden are illustrated for all 89 cases that showed ischaemic scar on both conventional bright-blood LGE and dark-blood LGE. A
significant bias (red solid line) of + 0.3 for dark-blood LGE was observed, with limits of agreement (blue dashed lines) at − 1.9 and + 2.4
Fig. 7 Short-axis bright-blood and dark-blood
phase sensitive inversion recovery (PSIR) LGE image of a subject with
non-ischaemic fibrosis. Image a: Conventional bright-blood PSIR LGE
short-axis image demonstrating the presence of mid-myocardial
enhancement in the basal to mid antero-lateral segment (blue
arrow). The orange arrow indicates a pericardial cyst/loculated
pericardial effusion in the context of thickened pericardium. In this
case, a diagnosis of previous myo-pericarditis was made on the basis
of CMR findings and clinical history. Image b: No evidence of mid-
myocardial enhancement was found on the dark-blood
PSIR LGE image. A non-perfect correspondence of the slice
positioning, most likely due to patient motion between acquisitions,
could have contributed to this discrepancy. In this case,
conventional LGE and dark-blood LGE were performed at 10 min
and 20 min post-injection, respectively. For specific scan details, see
‘Philips Achieva TX’ at Table 1
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readily available and does not require any scanner adjust-
ments and/or extensive optimizations.
Limitations
Although the proposed dark-blood LGE method shows
improved ischemic scar detection compared to conven-
tional bright-blood LGE in a large cohort of patients,
there was no histological confirmation. Importantly
however, 75% of the subjects who showed an ischemic
scar pattern on dark-blood LGE but not on bright-blood
LGE, had known coronary artery disease that was related
to the infarct territory. Whereas the authors feel the out-
comes to be related to the proposed dark-blood LGE
mechanism without using additional magnetization
preparation, future studies that use histological valid-
ation in preclinical models would be of great value.
As the appearance of the conventional bright-blood
and dark-blood LGE images are intrinsically different,
full blinding for image type was impossible for this
study. However, all LGE images were separated, anon-
ymized, and analysed in random order at different time-
points. Thereby, conventional bright-blood and dark-
blood LGE images were never presented in sequence to
the reader. Moreover, the readers were not informed of
the aim of the study or of the technical details of the se-
quences acquired. Therefore, all readers were, as far as
possible, blinded for image type in this study.
Although we also report on the detection of non-ischae-
mic fibrosis, papillary muscle enhancement, RV fibrosis,
and areas of LV thrombus, it should be stressed that the
present study was not designed to draw any conclusions
on these findings and therefore no p-values were provided.
Moreover, as many discrete patterns of non-ischemic fi-
brosis are described in this general referral cohort, the
present study would be underpowered to do so. As the
quality of novel dark- and black-blood techniques is much
debated for the detection of non-ischemic scar, future
studies should focus on a comparison with conventional
LGE regarding this type of scarring. Even though no con-
clusions are drawn on papillary muscle enhancement, the
prevalence of papillary muscle enhancement in patients
with MI in our study population is in agreement with
values from previous literature [33].
Finally, signal threshold-based analyses have been used
for LGE to delineate regions of scar. Exploring the impact
of the dark-blood LGE approach used in the present study
on signal threshold-based analyses was considered out-of-
scope, but may be of interest for future studies.
Conclusions
Dark-blood LGE is more sensitive for the detection of is-
chemic scar than conventional bright-blood LGE, on
both 1.5 T and 3 T MR scanners of different vendors,
without compromising the detection of non-ischemic
Fig. 8 Overall image quality of bright-blood and dark-blood LGE images. Overall image quality was scored as: 0) non-diagnostic, 1) low [≥ two
segments non-diagnostic], 2) medium [one segment non-diagnostic], or 3) high [all segments correctly identified]. The exact number of subjects
is given using the vertical axis, while percentages of the study population (n = 300) are indicated above each bar. Note that eight subjects had
non-diagnostic image quality and were excluded for further analysis
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scar and areas of thrombus. Furthermore, dark-blood
LGE showed higher average scar burden, increased over-
all image quality, and improved observer confidence. As
all these features are already achievable at 10 minutes
after contrast administration, this novel dark-blood LGE
approach emerges as a valuable and time-efficient diag-
nostic tool in the non-invasive assessment of myocardial
scar. The applicability in routine clinical practice is fur-
ther strengthened, as this approach is readily available
without the need for scanner adjustments and/or exten-
sive optimizations.
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